Atorvastatin 10mg

DRUG13 trials

Conditions

Cardiovascular Risk FactorDyslipidemiaDyslipidemiasEpilepsyHepatitis BHypercholesterolemia, DyslipidemiaHyperlipidemiaImmune Thrombocytopenia

Early Phase 1

Endothelial Function in Obstructive Sleep Apnea

CompletedNCT03122639

Columbia UniversityObstructive Sleep Apnea of Adult

Start: 2017-09-01End: 2021-05-07Updated: 2024-09-19

Phase 1

A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)

CompletedNCT01236430

Organon and CoHyperlipidemia

Start: 2011-02-28End: 2012-02-29Updated: 2022-02-16

Vascular Endothelial Dysfunction in Sleep Apnea

RecruitingNCT05289063

Columbia UniversityObstructive Sleep Apnea of Adult

Start: 2022-10-03End: 2027-02-28Target: 110Updated: 2026-02-13

Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet

Enrolling by invitationNCT06369571

Johns Hopkins UniversityDyslipidemia, Epilepsy

Start: 2024-10-04End: 2027-12-31Target: 22Updated: 2025-10-09

Phase 2

Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma

TerminatedNCT03275376

Taichung Veterans General HospitalOverall Survival, Tumor Responses

Start: 2017-12-21End: 2021-03-13Updated: 2021-03-16

Atorvastatin in Management of Newly Diagnosed ITP

NCT03692754

Shandong UniversityImmune Thrombocytopenia, Purpura, Thrombocytopenic

Start: 2021-11-01End: 2023-12-01Target: 30Updated: 2021-09-05

Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial

NCT05483894

Samsung Medical CenterHepatitis B, Portal Hypertension

Start: 2022-08-01End: 2025-01-31Target: 36Updated: 2022-08-02

Phase 3

Effect of 80-mg Atorvastatin on Myocardial Edema

CompletedNCT02901379

National Cardiovascular Center Harapan Kita Hospital IndonesiaMyocardial Edema

Start: 2016-10-31End: 2018-08-31Updated: 2018-08-23

Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia

NCT03464682

Zhejiang Hisun Pharmaceutical Co. Ltd.Primary Hypercholesterolemia

Start: 2015-02-28End: 2019-05-28Target: 720Updated: 2018-10-18

Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population

NCT03696940

Laboratorios Grossman, S.A.Cardiovascular Risk Factor, Dyslipidemias

Start: 2018-05-28End: 2019-08-31Updated: 2019-02-26

Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A

CompletedNCT05970679

Daewon Pharmaceutical Co., Ltd.Hypercholesterolemia, Dyslipidemia

Start: 2022-08-17End: 2023-04-13Updated: 2023-08-01

Phase 4

Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia

CompletedNCT03906539

All India Institute of Medical Sciences, BhubaneswarDyslipidemias

Start: 2019-05-22End: 2021-12-31Updated: 2022-04-06

Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis

TerminatedNCT04072601

Copenhagen University Hospital, HvidovreLiver Cirrhoses

Start: 2019-11-08End: 2023-01-10Updated: 2023-01-13

Clinical Cardiology2025-05-011 citations

Review of the role of statins in cirrhosis and portal hypertension

Clinical Liver Disease2023-04-2711 citations

Statins Restore Endothelial Protection against Complement Activity in Obstructive Sleep Apnea: A Randomized Clinical Trial

Annals of the American Thoracic Society2023-03-1322 citations

Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial

BMJ Open2020-01-0113 citations